Clinical manifestations and anti-phospholipid antibodies in 712 patients with systemic lupus erythematosus: evaluation of two diagnostic assays

International consensus guidelines on anticardiolipin and anti-β2-glycoprotein I testing: Report from the 13th International Congress on Antiphospholipid Antibodies

(2011) Gabriella Lakos et al.   ARTHRITIS AND RHEUMATISM

Antiphospholipid syndrome: laboratory detection, mechanisms of action and treatment

(2011) A. Tripodi et al.   JOURNAL OF INTERNAL MEDICINE

Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study

(2011) L Stojanovich et al.   LUPUS

Evaluation of a new set of automated chemiluminescense assays for anticardiolipin and anti-beta2-glycoprotein I antibodies in the laboratory diagnosis of the antiphospholipid syndrome

(2011) Lies Persijn et al.   THROMBOSIS RESEARCH

IgM Anti-ß2 Glycoprotein I Is Protective Against Lupus Nephritis and Renal Damage in Systemic Lupus Erythematosus

(2010) TARANEH MEHRANI et al.   JOURNAL OF RHEUMATOLOGY

Update on anti-phospholipid antibodies in SLE: the Hopkins’ Lupus Cohort

(2010) M. Petri   LUPUS

Antiphospholipid syndrome: critical analysis of the diagnostic path

(2010) V. Pengo et al.   LUPUS

Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice

(2010) RAS Roubey   LUPUS

Antiphospholipid antibody profile: implications for the evaluation and management of patients

(2010) A. Tincani et al.   LUPUS

Accuracy of the First Fully Automated Method for Anti-cardiolipin and Anti-β2 Glycoprotein I Antibody Detection for the Diagnosis of Antiphospholipid Syndrome

(2009) D. Villalta et al.   Annals of the New York Academy of Sciences

A STAT4 risk allele is associated with ischaemic cerebrovascular events and anti-phospholipid antibodies in systemic lupus erythematosus

(2009) E. Svenungsson et al.   ANNALS OF THE RHEUMATIC DISEASES

Clinical course of high-risk patients diagnosed with antiphospholipid syndrome

(2009) V. PENGO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Moderate versus high-titer persistently anticardiolipin antibody positive patients: Are they clinically different and does high-titer anti-β2-glycoprotein-I antibody positivity offer additional predictive information?

(2009) D. Erkan et al.   LUPUS

Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study

(2009) Johanna Gustafsson et al.   ARTHRITIS RESEARCH & THERAPY

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

(2008) R Cervera et al.   ANNALS OF THE RHEUMATIC DISEASES

Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification

(2008) A. RUFFATTI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Clinical Utility of Laboratory Tests Used to Identify Antiphospholipid Antibodies and to Diagnose the Antiphospholipid Syndrome

(2008) Monica Galli   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Laboratory classification categories and pregnancy outcome in patients with primary antiphospholipid syndrome prescribed antithrombotic therapy

(2008) A. Ruffatti et al.   THROMBOSIS RESEARCH